ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates
MHRA Drug Safety Updates

 

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update December 2020-DSU-PDF-1712.pdf

Drug Safety Update December 2020-DSU-PDF-1712.pdf
Summary: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium. Venetoclax (Venclyxtoâ–¼): updated recommendations on tumour lysis syndrome (TLS). Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus.
File Size: 263KB
File Type: application/pdf
Created: 10 December 2021
Last Modified: 03 March 2022